Myths vs facts: FADS1 and allergy

Myth: Your FADS1 genotype alone can predict your risk for allergies like hay fever, asthma, or eczema. Fact: FADS1 variants (e.g., rs174546) influence the activity of delta-5 desaturase, an enzyme involved in converting omega-6 and omega-3 fatty acids. Some studies have linked certain variants to altered levels of inflammatory mediators and a modestly increased risk of allergic diseases. However, the effect sizes are small and not consistent across populations. Many other genetic and environmental factors—such as early-life exposures, diet, microbiome, and other immune-related genes—play a much larger role. Another myth is that taking specific supplements (e.g., evening primrose oil or fish oil) based on your FADS1 genotype can prevent or treat allergies. While there is some mechanistic plausibility, clinical trials have not shown reliable benefits. Current evidence does not support routine genetic testing for allergy risk prediction or personalized supplementation. In summary, FADS1 is one piece of a complex puzzle, but it is not a standalone predictor or actionable target for allergy management. Focus on evidence-based allergy prevention and treatment, such as allergen avoidance, medications, and immunotherapy.